about
Patient engagement and patient support programs in allergy immunotherapy: a call to action for improving long-term adherenceSublingual immunotherapy in allergic rhinitis: efficacy, safety, adherence and guidelinesTherapeutic interventions in severe asthmaDifferential Plasma-cell evolution is linked with Dermatophagoides pteronyssinus immunotherapy response.Allergic diseases in the elderly: biological characteristics and main immunological and non-immunological mechanisms.Clinical practice recommendations for allergen-specific immunotherapy in children: the Italian consensus reportSublingual immunotherapy for allergic rhinitis and conjunctivitis.Sublingual immunotherapy in preschool children: an update.Specific immunotherapy in asthma: a comprehensive review.Optimal duration of allergen immunotherapy in children with dust mite respiratory allergy.Efficacy and safety of sublingual immunotherapy in children.Benefit of SLIT and SCIT for Allergic Rhinitis and Asthma.Allergen immunotherapy in asthma; what is new?AIT (allergen immunotherapy): a model for the "precision medicine".Dermatophagoides pteronyssinus immunotherapy changes the T-regulatory cell activity.The perception of allergen-specific immunotherapy among pediatricians in the primary care settingEffect of adjuvanted and standard sublingual immunotherapy on respiratory function in pure rhinitis due to house dust mite over a 5-year period.Physician's recommendation and explanation is important in the initiation and maintenance of allergen immunotherapy.Initial immunological changes as predictors for house dust mite immunotherapy response.Allergen immunotherapy on the way to product-based evaluation-a WAO statement.Adherence to sublingual immunotherapy in preschool children.100 years of immunotherapy: the Monaco charter. under the high patronage of His Serene Highness Prince Albert II of Monaco.Tregitope-linked Refined Allergen Vaccines for Immunotherapy in Cockroach Allergy
P2860
Q26740381-FDC7A808-57FC-409B-B1CA-1F6624F9C40FQ27002341-2D9D5252-82A6-4702-80F8-56C39B6DA026Q28079238-7EF38B65-802A-4BDC-AEE7-E7AF4EB44E2BQ30402227-DDBCB97B-15A2-44F6-AD9A-30A1838177F6Q37623049-5F728EB7-33B7-4E6C-8221-E450BA6E4CDDQ37696401-68D3AD64-E1B4-48AD-A8AC-F2087F06EFD3Q38085032-3F936401-773E-4656-B069-4F367D42855AQ38096032-1473D612-B452-4646-AC40-B2947138A59DQ38161996-3D02F860-90B2-49B2-97AB-AAF7C36E2353Q38265953-77E29281-DBDE-4FBE-8668-AFA2877167E3Q38615030-C66DC75A-9319-4997-9F5A-AA4473887912Q39037216-A546E09E-684D-4D0C-BC19-4F59FE570323Q39038000-44BDFD4B-5B64-4E5B-B8FC-91C2477B94A4Q41134553-22525E9E-3220-4668-A4CA-5BCDBD958905Q41697162-04500983-35D1-45AF-A6C2-CF8EA24DB3F7Q41820059-1C0D007B-667A-4640-8F4C-0474E571EBC1Q41854493-5252C251-6222-4742-BDFB-F52FE5479AE7Q42019552-FDC0D01C-1B47-4CA2-939A-EB1085C34420Q42477747-5CB4A90F-0680-4B74-88FB-C1A1E9051EF5Q43249691-73383FFC-BE0A-4685-9BF3-85217E86616AQ43502504-15CBB098-C0D1-4341-8AED-81139572A9ECQ46354879-D22DC591-E81F-4AF6-8B9A-316972D7B949Q57811623-45109ACF-A33F-47FD-AA57-7292A94F6719
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Specific immunotherapy: beyond the clinical scores.
@en
Specific immunotherapy: beyond the clinical scores.
@nl
type
label
Specific immunotherapy: beyond the clinical scores.
@en
Specific immunotherapy: beyond the clinical scores.
@nl
prefLabel
Specific immunotherapy: beyond the clinical scores.
@en
Specific immunotherapy: beyond the clinical scores.
@nl
P1476
Specific immunotherapy: beyond the clinical scores.
@en
P304
P356
10.1016/J.ANAI.2011.04.017
P577
2011-06-12T00:00:00Z